We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDRX PETITION SHOWS NEW APPROACH TO AUTHORIZED GENERICS
ANDRX PETITION SHOWS NEW APPROACH TO AUTHORIZED GENERICS
January 11, 2005
Andrx Pharmaceuticals has filed a citizen’s petition with the FDA requesting that the agency seek the advice of the Federal Trade Commission (FTC) and the Justice Department on the contentious issue of authorized generics.